Prolia (Denosumab) Injection Cost in 2026, and How to Lower It
A single Prolia (denosumab) injection is commonly billed at $1,500 to $2,500 per dose for osteoporosis, given every 6 months. The two biggest levers are switching to a biosimilar and using the right assistance program, and if you qualify, the maker can provide the drug free.
- Prolia is a 60 mg subcutaneous injection (billed under J-code J0897) given every 6 months for osteoporosis, not an IV infusion, so the biggest levers are the drug version and the assistance program, not the infusion site.
- Denosumab biosimilars (Jubbonti and Wyost, Ospomyv and Xbryk) are the same class of medicine at a lower price. Whether one is right for you is a decision for you and your prescriber.
- If you are uninsured or your plan will not cover it, Amgen runs patient assistance (the Amgen Safety Net Foundation free-drug program for those who qualify) and a copay program for the commercially insured. On Medicare, use a charity copay fund instead.
What a Prolia Injection Costs
Prolia is a fixed 60 mg subcutaneous injection billed under J-code J0897, given twice a year. The same molecule is also sold as Xgeva at a higher 120 mg dose for cancer-related bone disease, which is billed more often and costs more. These are national estimates; your bill depends on the version, site, and plan.
| Version | Typical billed cost per dose |
|---|---|
| Prolia (60 mg, osteoporosis) | ~$1,500 to $2,500 |
| Xgeva (120 mg, cancer bone disease) | higher, more frequent |
| Biosimilar (Jubbonti/Wyost, Ospomyv/Xbryk) | less |
| With manufacturer free-drug program | as low as $0 (drug) |
Prolia is given every 6 months, so the cost recurs twice a year, which is why the biosimilar and assistance levers matter so much.
Already got a bill for your Prolia (denosumab) injection? Check if you were overcharged.
A typical Prolia (denosumab) injection runs $1,500 to $2,500 without insurance. Enter what you were charged and we will flag it.
Or send us the bill and we will fight it down. 64% of cases reduced.
How to Lower the Cost
Ask about a denosumab biosimilar
Jubbonti and Wyost, and Ospomyv and Xbryk, are FDA-approved denosumab biosimilars that cost less than Prolia and Xgeva. Many plans prefer them. Whether to switch is a decision for you and your prescriber, but it is worth raising.
Use the right assistance for your situation
Uninsured or not covered? The Amgen Safety Net Foundation may provide Prolia free under an income limit if you qualify. Commercially insured? The Amgen copay program can cut your coinsurance. On Medicare? Use a charity fund like the PAN or HealthWell Foundation. Our help paying for medication tool and our guide to patient assistance programs point you to the right one.
Confirm whether a facility fee was added
Prolia is a quick injection, but a hospital outpatient department can still add a facility fee on top of the drug. Getting the shot at an in-network doctor’s office instead can avoid that fee. Where you get it is worth confirming with your prescriber and plan.
Check the bill for errors, especially the J-code units
Prolia is billed under J0897, and a units or facility-fee error can multiply the charge, or Prolia can be mixed up with the higher-dose Xgeva. CareRoute Bill Defense checks the units, drug wastage, facility fees, and network status, and disputes errors, with no fee unless we save you money.
Frequently Asked Questions
How much does a Prolia injection cost?
A single Prolia (denosumab) injection is commonly billed at about $1,500 to $2,500 per dose, given every 6 months for osteoporosis. A hospital outpatient department can add a facility fee on top. Your exact cost depends on the site and plan.
What is the difference between Prolia and Xgeva?
Prolia and Xgeva are the same molecule, denosumab, but different products. Prolia is a 60 mg dose every 6 months for osteoporosis, while Xgeva is a 120 mg dose given far more often for cancer-related bone disease, so Xgeva costs much more per year. Which is appropriate is a decision for you and your prescriber.
Is a biosimilar as good as Prolia, and is it cheaper?
Denosumab biosimilars (Jubbonti and Wyost, Ospomyv and Xbryk) are FDA-approved as highly similar to Prolia and Xgeva with no clinically meaningful differences, and they generally cost less. Whether to use one is a decision between you and your prescriber, and many plans prefer them.
Can I get Prolia for free?
If you are uninsured, or insured but your plan will not cover it, and your income is under the program limit, the Amgen Safety Net Foundation may provide Prolia at no cost if you qualify. Commercially insured patients can use the Amgen copay program, and Medicare patients can use independent charity funds. Our help-paying-for-medication tool points you to the program that fits your situation.
Will my insurance out-of-pocket maximum cap what I pay?
For in-network, covered care, yes. Once you hit your plan’s out-of-pocket maximum, it covers 100% of remaining in-network covered costs for the year. But an out-of-network site or provider can bill amounts that do not count toward that cap, which is why confirming network status of every party matters.
Related
Sources
- CMS Average Sales Price (ASP) drug pricing files (J0897 denosumab)
- FDA (denosumab biosimilar approvals: Jubbonti, Wyost, Ospomyv, Xbryk)
- Health Care Cost Institute and AHA (drug and facility-fee estimates)
- Amgen patient support programs (Amgen Safety Net Foundation free-drug eligibility and Amgen copay program)
Prices are national estimates for 2026 and vary widely by version, site, and plan. Any change of drug is a decision for you and your prescriber. This page is educational and is not medical or financial advice. Last updated August 2026.